We need women ages 18-70 in Urbana and Springfield, IL, diagnosed with Stage 0 (DCIS), I, II, or IIIa breast cancer at some point in their lives.
This study is evaluating the effectiveness of the BEAT Cancer program for breast cancer survivors. The research team will compare the effects of the intervention to usual care (written materials about exercise for cancer survivors) on short- and longer-term physical activity adherence among breast cancer survivors.
Learn more and sign up today.
Phase 1b Trial of 2nd Generation Designer T Cells in Metastatic Breast Cancer
We need women or men with stage IV, metastatic breast cancer who live near or are willing to travel to the Roger Williams Medical Center in Providence, Rhode Island. The purpose of this Phase Ib clinical trial is to determine whether a high dose of designer T cells is better when given with or without interleukin 2 (IL2), a drug that is thought to stimulate the immune system. The researcher would like to enroll about 12 people who have received at least two prior chemotherapies that failed OR at least one prior hormonal therapy and one prior chemotherapy that failed. Find out more and sign up.
Breast Cancer Cognitive Rehabilitation Study
We need women in the Los Angeles area, ages 21-65, who were diagnosed with Stage I, II, or III breast cancer between 18 months and 5 years ago and are experiencing cognitive problems (for example, memory loss and concentration problems) that interfere with everyday activities. The purpose of this study is to evaluate the effectiveness of a rehabilitation group intervention program for breast cancer survivors who are experiencing memory loss and concentration problems associated with cancer treatments. Find out more and sign up.
Genomic Markers of Breast Cancer Prevention Induced by hCG in Women at High Risk (GEMCP Study)
We need women ages 20-40 in the Rochester, MN, Philadelphia, or Dallas areas who have tested positive for a BRCA1 or 2 mutation and have NOT had cancer. Because pregnancy and breastfeeding appear to reduce breast cancer risk in women, including those with a BRCA1 or 2 mutation, researchers are interested in seeing if giving hormones that mimic pregnancy can change these high risk women’s breast tissue in ways that appear to reduce their risk. Find out more and sign up.